ArticleJournal of hematology & oncology2015

Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome.

Seunghoon Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.